Comparison of Muscle Regeneration after BMSC-Conditioned Medium, Syngeneic, or Allogeneic BMSC Injection

Cells. 2022 Sep 12;11(18):2843. doi: 10.3390/cells11182843.

Abstract

For many years optimal treatment for dysfunctional skeletal muscle characterized, for example, by impaired or limited regeneration, has been searched. Among the crucial factors enabling its development is finding the appropriate source of cells, which could participate in tissue reconstruction or serve as an immunomodulating agent (limiting immune response as well as fibrosis, that is, connective tissue formation), after transplantation to regenerating muscles. MSCs, including those derived from bone marrow, are considered for such applications in terms of their immunomodulatory properties, as their naive myogenic potential is rather limited. Injection of autologous (syngeneic) or allogeneic BMSCs has been or is currently being tested and compared in many potential clinical treatments. In the present study, we verified which approach, that is, the transplantation of either syngeneic or allogeneic BMSCs or the injection of BMSC-conditioned medium, would be the most beneficial for skeletal muscle regeneration. To properly assess the influence of the tested treatments on the inflammation, the experiments were carried out using immunocompetent mice, which allowed us to observe immune response. Combined analysis of muscle histology, immune cell infiltration, and levels of selected chemokines, cytokines, and growth factors important for muscle regeneration, showed that muscle injection with BMSC-conditioned medium is the most beneficial strategy, as it resulted in reduced inflammation and fibrosis development, together with enhanced new fiber formation, which may be related to, i.e., elevated level of IGF-1. In contrast, transplantation of allogeneic BMSCs to injured muscles resulted in a visible increase in the immune response, which hindered regeneration by promoting connective tissue formation. In comparison, syngeneic BMSC injection, although not detrimental to muscle regeneration, did not result in such significant improvement as CM injection.

Keywords: bone marrow-derived stromal cells; conditioned medium; immune response; immunomodulation; inflammation; regeneration; skeletal muscle; transplantation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Culture Media, Conditioned / metabolism
  • Culture Media, Conditioned / pharmacology
  • Cytokines / metabolism
  • Fibrosis
  • Hematopoietic Stem Cell Transplantation*
  • Inflammation / metabolism
  • Insulin-Like Growth Factor I / metabolism
  • Mesenchymal Stem Cells* / metabolism
  • Mice
  • Muscle, Skeletal

Substances

  • Culture Media, Conditioned
  • Cytokines
  • Insulin-Like Growth Factor I

Grants and funding

The research was funded by the National Science Centre (Poland), grant number 2016/23/N/NZ6/00565 for Barbara Świerczek-Lasek. Part of the study was carried out with the infrastructure of Center for Preclinical Research, Medical University of Warsaw, Warsaw, Poland, financed by the European Union through the European Regional Development Fund within operational program Innovative Economy for 2007–2013.